Arena Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Corporate Update on November 4
14 Ottobre 2021 - 10:05PM
Business Wire
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its
third quarter 2021 financial results and provide a corporate update
on Thursday, November 4, 2021, after the close of the U.S.
financial markets. The Company will host a question and answer
session via conference call and live webcast with the investment
community the same day at 4:30 PM ET.
Conference Call & Webcast Information
When: Thursday, November 4, 2021, at 4:30 PM ET Webcast:
Conference call will be broadcast live in listen-only mode on the
company’s investor relations website at
https://invest.arenapharm.com/events-presentations
A recording of the conference call will be archived for 30 days
after the call.
About Arena Pharmaceuticals
ARENA Pharmaceuticals is a team with a singular purpose –
deliver important medicines to patients.
In a rapidly changing global market, we work with a sense of
urgency every day to understand the needs of all our stakeholders,
identify bold, sometimes disruptive, ideas to get medicines to
patients, and relentlessly execute until it’s done.
ARENA - Care More. Act Differently.
Forward-Looking Statements
Certain statements in this press release are forward-looking
statements that involve a number of risks and uncertainties. Such
forward-looking statements include statements about Arena's
corporate update webcast, purpose, work, ideas, and execution. For
such statements, Arena claims the protection of the Private
Securities Litigation Reform Act of 1995. Actual events or results
may differ materially from Arena's expectations. Factors that could
cause actual results to differ materially from the forward-looking
statements include those disclosed in Arena's filings with the
Securities and Exchange Commission. These forward-looking
statements represent Arena's judgment as of the time of this
release. Arena disclaims any intent or obligation to update these
forward-looking statements, other than as may be required under
applicable law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211014005079/en/
Corporate Contact: Patrick Malloy Arena Pharmaceuticals,
Inc. Vice President, Investor Relations & Corporate
Communications pmalloy@arenapharm.com 847.987.4878
Grafico Azioni Arena Pharmaceuticals (NASDAQ:ARNA)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Arena Pharmaceuticals (NASDAQ:ARNA)
Storico
Da Mag 2023 a Mag 2024